- Home
- IVDA vs VRAX Comparison
IVDA vs VRAX Comparison
Compare IVDA & VRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVDA
- VRAX
- Stock Information
- Founded
- IVDA 2003
- VRAX 2013
- Country
- IVDA United States
- VRAX United Kingdom
- Employees
- IVDA N/A
- VRAX N/A
- Industry
- IVDA Computer Software: Prepackaged Software
- VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- IVDA Technology
- VRAX Health Care
- Exchange
- IVDA Nasdaq
- VRAX Nasdaq
- Market Cap
- IVDA 4.3M
- VRAX 4.4M
- IPO Year
- IVDA N/A
- VRAX 2022
- Fundamental
- Price
- IVDA $1.58
- VRAX $0.65
- Analyst Decision
- IVDA
- VRAX Strong Buy
- Analyst Count
- IVDA 0
- VRAX 1
- Target Price
- IVDA N/A
- VRAX $3.00
- AVG Volume (30 Days)
- IVDA 5.5M
- VRAX 340.5K
- Earning Date
- IVDA 11-13-2025
- VRAX 01-01-0001
- Dividend Yield
- IVDA N/A
- VRAX N/A
- EPS Growth
- IVDA N/A
- VRAX N/A
- EPS
- IVDA N/A
- VRAX N/A
- Revenue
- IVDA $7,142,302.00
- VRAX $6,331.00
- Revenue This Year
- IVDA $340.48
- VRAX $217,274.83
- Revenue Next Year
- IVDA N/A
- VRAX N/A
- P/E Ratio
- IVDA N/A
- VRAX N/A
- Revenue Growth
- IVDA 88.96
- VRAX N/A
- 52 Week Low
- IVDA $1.15
- VRAX $0.52
- 52 Week High
- IVDA $8.05
- VRAX $3.62
- Technical
- Relative Strength Index (RSI)
- IVDA 50.34
- VRAX 48.77
- Support Level
- IVDA $1.46
- VRAX $0.61
- Resistance Level
- IVDA $2.24
- VRAX $0.63
- Average True Range (ATR)
- IVDA 0.17
- VRAX 0.03
- MACD
- IVDA 0.04
- VRAX 0.01
- Stochastic Oscillator
- IVDA 37.62
- VRAX 69.63
About IVDA Iveda Solutions Inc.
Iveda Solutions Inc offers smart city technologies globally, offering advanced AI-driven video surveillance solutions and a robust suite of Internet of Things (IoT) platforms that power digital transformation for cities and commercial clients worldwide. The smart cities market, as well as the AI and IoT segments, are poised for significant growth in the coming years. The company offers AI-intelligent video search, smart utility, smart sensors, gateways, and trackers, and IoT platforms (Products).
About VRAX Virax Biolabs Group Limited
Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes (HSV-1) and Human Papillomavirus (HPV).